Today Mariam Hakobyan successfully defended her PhD thesis with a stellar presentation! 💪🏻🥳💐🎉Huge congrats and very well deserved Dr. Hakobyan!🎓 Translational Cancer Epigenomics DKFZ

Great opportunity in a great lab in a cool research environment!

We are looking for a motivated #postdoc with experience in #CRISPR and #mousemodels. Join us at our new lab Universitätsklinikum Heidelberg, @KITZ_HD to study #acuteleukemia vulnerabilities. More details: karriere.klinikum.uni-heidelberg.de/index.php?ac=j…

Monday March 4, 16.00 CET Virtual Erasmus Hematology Lecture Daniel Matson , University of Wisconsin with: "Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia" Link: us06web.zoom.us/j/83009472100 Daniel Matson Laboratory

Interesting method for #singlecell transcriptomic analysis of rare cell types: biorxiv.org/content/10.110…

Looking for a #postdoc in #epigenomics and #CancerResearch ? 👉Maybe this opportunity DKFZ is right for you! Application deadline is Sept 15th! dkfz.de/en/postdoc-pro…

POSTDOC OPPORTUNITY TO JOIN US! Are you interested in how nuclear metabolism impacts on chromatin function and gene regulation in leukemia? Apply for an attractive postdoc position with us through the MSCA @carrerasleaders program! More info here: buschbecklab.org/join-us/

I'm excited to share our preprint "Pyjacker identifies enhancer hijacking events in acute myeloid leukemia including MNX1 activation via deletion 7q": doi.org/10.1101/2024.0…. This is my main PhD work and a massive collaborative effort. 🧵👇

This collaborative effort demonstrates that ectopic expression of MNX1 is a driver event in a subset of adult del(7q) AML. #AML #leukemia #epigenomics

Excited to announce the upcoming 80th Heidelberg Grand Round on "Developmental Signatures and Molecular Plasticity in Cancer"! Join us in Heidelberg, on Nov 14, 2024, from 4:00-6:00 PM–free of charge! Explore #Cancer as a developmental disease! DKFZ NCT Heidelberg Universitätsklinikum Heidelberg

We are hiring! For our Translational Cancer Epigenomics team DKFZ and NCT Heidelberg we are looking for a talented postdoc interested in research on heme malignancies and #epigenetics. 🧬🧪🩸 Interested? 👉See jobs.dkfz.de/en/jobs/167620… or DM me!

Our work on aberrant MNX1 expression in AML caused by enhancer hijacking is finally out! Great collaboration between the Plass lab, Translational Cancer Epigenomics and many others! Thanks a lot to everyone involved! 🙋🏻‍♂️

Breaking news! The Erasmus Hematology Lectures start again on September 1 with Marc Dawson. As Marc presents from Australia this lecture will be at 1pm CEST! All other lecture will be at 4PM CEST! Check out the complete list of speakers for 2025! Enjoy and share the news!

+++ Postdoc Opportunity +++ Translational Cancer Epigenomics is looking for researchers interested in combining cutting edge #genomics, #epigenetics and #AI for precision oncology in pediatric #leukemia. dkfz.de/fileadmin/user… Applications via the #DKFZ postdoc program: dkfz.de/en/karriere/in…

Just published in Blood Cancer Discovery: Molecular Plasticity Results in #Oncofetal #Reprogramming and Therapeutic Vulnerabilities in JMML, by Mark Hartmann @dlipka1 Check out new insights into cell-of-origin, and repurposing anti-CD52. doi.org/10.1158/2643-3…

Happy to see our study finally published in Blood Cancer Discovery! 🎉 Thanks again to the lead authors Mark Hartmann, Maximilian Schönung and all collaborators who helped to put together the bits and pieces of this exciting story! 🙏👏

ONLINE FIRST ALERT! Molecular #Plasticity Results in #Oncofetal #Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia aacrjournals.org/bloodcancerdis… Blood Cancer Discovery AACR #childhoodcancer #epigenetics #precisiononcology

Interested in DNA methylation and want to hear what we can learn from it regarding lineage commitment decisions in #hematopoiesis? #ASH25 #epigenomics

Yet another work that investigates the molecular underpinnings of #childhood #leukemia and tries to understand what drives disease #heterogeneity across patients. Congratulations to this amazing work Elvin Wagenblast and colleagues!